Current Liabilities
Operating Lease Liabilities (Current)
Royalty Pharma Operating Lease Liabilities (Current) decreased by 4.0% to $18.49M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026
How to read this metric
An increase indicates higher near-term cash outflows for leases, potentially pressuring short-term liquidity.
Detailed definition
This represents the portion of total operating lease obligations that are due to be paid within the next twelve months....
Peer comparison
Commonly reported by all companies with significant lease portfolios.
Metric ID:
operating_lease_liabilities_currentHistorical Data
4 periods
| Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $20.77M | $20.02M | $19.26M | $18.49M |
| QoQ Change | — | -3.6% | -3.8% | -4.0% |
Range$18.49M – $20.77M
Current Streak3+ quarters decline
Operating Lease Liabilities (Current) at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's operating lease liabilities (current)?
- Royalty Pharma (RPRX) reported operating lease liabilities (current) of $18.49M in Q1 2026.
- What does operating lease liabilities (current) mean?
- The amount of lease payments due within one year.